Takeda UK Ltd

Takeda House, Mercury Park, Wycombe Lane, Wooburn Green, High Wycombe, Buckinghamshire, HP10 0HH
Telephone: +44 (0)1628 537 900
Fax: +44 (0)1628 526 615
WWW: http://www.Takeda.co.uk
Medical Information Direct Line: +44 (0)1628 537 900
Medical Information e-mail: medinfo@takeda.co.uk
Medical Information Fax: +44 (0)1628 526 617

Patient Information Leaflet last updated on the eMC: 02/07/2010
PIL Prostap 3 Leuprorelin Acetate Depot Injection 11.25mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 02/07/2010 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 22/07/2009 and displayed until 02/07/2010
Reasons for adding or updating:
  • Change of manufacturer
  • Change to Marketing Authorisation Holder
Updated on 07/04/2009 and displayed until 22/07/2009
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to Further Information section
  • Change to date of revision
Updated on 06/06/2008 and displayed until 07/04/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to date of revision
  • Change to side-effects
Updated on 03/02/2005 and displayed until 06/06/2008
Reasons for adding or updating:
  • Change of licence holder
Updated on 10/11/2004 and displayed until 03/02/2005
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to storage instructions
Updated on 17/11/2003 and displayed until 10/11/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 15/01/2003 and displayed until 17/11/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 29/05/2001 and displayed until 15/01/2003
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   leuprorelin acetate